Arcellx · 3 hours ago
Senior Cell Therapy Account Manager (Baltimore)
Arcellx is a public, clinical-stage biotechnology company focused on innovative cell therapies for cancer treatment. The Senior Cell Therapy Account Manager will drive sales and strategic account management to enhance the adoption of Arcellx's cell therapy products across treatment centers, aiming to transform outcomes for patients with multiple myeloma.
BiopharmaBiotechnologyHealth CareLife SciencePharmaceutical
Responsibilities
Drive multiple myeloma CAR-T brand choice within authorized treatment centers (ATCs) and community-based accounts
Competitively sell Arcellx products through a deep knowledge of the multiple myeloma landscape and best-in-class clinical expertise
Effectively navigate complex account environments by identifying and understanding the needs and challenges of diverse stakeholders and collaborate with internal teams to provide targeted support
Integrate customer insights and analytical data to design and execute strategic account plans. Develop a deep understanding of customer dynamics and market trends to identify opportunities, uncover barriers to treatment, and drive actionable insights
Share relevant account and HCP insights with cross-functional and alliance partners, highlighting business trends, competitive shifts, and changes in the therapeutic landscape. Support alliance partners to ensure the patient experience is positive and seamless
Equip ATC staff with CAR-T process training that will eliminate barriers to use and optimize operational workflows
Operate in strict compliance with all laws, regulations, company policies, and ethical standards, including protection of patient-identifiable data
Qualification
Required
Master's or bachelor's degree required
5+ years of hematology/oncology therapeutic experience required
Proven and consistent history of meeting or exceeding sales objectives in complex, competitive, high-value therapeutic areas
Demonstrated ability to manage large, strategic accounts and navigate complex academic hospital systems in collaboration with cross-functional and co-marketing partners
Willingness to travel overnight up to 50%
Preferred
Experience in cell therapy, immunotherapy, and/or multiple myeloma strongly preferred, along with a strong understanding of oncology market dynamics
Experience with new product launches within academic hospitals or specialty markets is strongly preferred
Benefits
100% coverage for medical, dental and vision for team members and dependents
Unlimited vacation
A 3-day weekend every month
Fully-paid parental leave for up to 6 months
Tuition reimbursement
401k employer contribution
Company
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Funding
Current Stage
Public CompanyTotal Funding
$622MKey Investors
Kite Pharma
2023-11-15Post Ipo Equity· $200M
2022-12-09Post Ipo Equity· $100M
2022-06-15Post Ipo Equity· $112M
Leadership Team
Recent News
2025-12-11
2025-12-08
Company data provided by crunchbase